Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Magic mushrooms tested for alcoholism in tiny oregon study

NCT ID NCT07189988

Disease control Sponsor: Healing Advocacy Fund Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This pilot study follows 20 adults in Oregon who are using psilocybin (the active ingredient in magic mushrooms) to help with alcohol use disorder. Researchers are observing how often participants have heavy drinking days before and after psilocybin sessions. The study does not provide treatment itself—it simply watches what happens in a real-world clinic setting.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
psilocybin
What this could lead to
If successful, this could point toward psilocybin as a helpful tool for reducing heavy drinking in people with alcohol use disorder.
What could go wrong
This is a very small, early observational study with only 20 participants and no control group. Results may not apply to everyone, and psilocybin can cause intense psychological experiences.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

20 people

The number who actually took part.

Started

Mar 2025

Expected to finish

Aug 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Study participants will be recruited through Oregon's Innertrek Patient Service Center (PSC). They will exhibit struggles with alcoholism or alcohol use disorder, deemed appropriate for care by Oregon's Innertrek Patient Service Center, and eligible for psilocybin services. Once eligibility at the PSC has been determined, eligible participants will be invited to voluntarily participate in the People Science pilot observational research study.

Ages

21 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion 1. Over 21 years old and reside in Portland, Oregon (all genders) 2. Have a personal smartphone device, internet access, and willing to download Chloe 3. Have been deemed appropriate for care by Oregon's Innertrek Patient Service Center (PSC) and eligible for psilocybin services 4. Willingness to complete study activities and assessments for the duration of the study Exclusion Note that #1-3 below are mandatory exclusions for psilocybin-assisted care as directed by the Oregon Health Authority. Any potential participant who: 1. Have a personal history of psychosis per the Oregon Health Authority 2. Have active use of lithium per the Oregon Health Authority 3. Exhibit active thoughts of suicidality per the Oregon Health Authority 4. Are deemed ineligible for psilocybin services by Oregon's Innertrek Patient Service Center (PSC)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Alcohol use disorder are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

alcohol abuse

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Alcohol use disorder

Contacts and locations

Locations

  • Innertrek Patient Service Center

    Portland, Oregon, 97232, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.